WuXi AppTec Co., Ltd. - Jan 1, 2023 Form 3 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
10%+ Owner
Signature
WuXi AppTec Co., Ltd., By: /s/ Edward Hu, Director
Stock symbol
AMAM
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 05:34 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMAM Ordinary Shares 21.3M Jan 1, 2023 Held by WuXi PharmaTech Healthcare Fund I, L.P. F1, F2
holding AMAM Ordinary Shares 8M Jan 1, 2023 Held by WuXi AppTec (Hong Kong) Holding Limited F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
F2 Shares are directly held by WuXi PharmaTech Healthcare Fund I, L.P. ("PharmaTech"). PharmaTech is an indirect, wholly owned subsidiary of WuXi AppTec Co., Ltd. ("AppTec Co"), which is the ultimate beneficial owner of PharmaTech and shares voting and investment authority over these shares.
F3 Shares are directly held by WuXi AppTec (Hong Kong) Holding Limited ("AppTec HK"). AppTec HK is an indirect, wholly owned subsidiary of AppTec Co, which is the ultimate beneficial owner of AppTec HK and shares voting and investment authority over these shares.